Bio-Thera Solutions Ltd Market Cap ($1.08 Billion)
Market Cap & Net Worth: Bio-Thera Solutions Ltd (688177)
Bio-Thera Solutions Ltd market cap. Bio-Thera Solutions Ltd (SHG:688177) has a market capitalization of $1.08 Billion (CN¥7.36 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #8283 globally and #1887 in its home market, demonstrating a 4.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-Thera Solutions Ltd's stock price CN¥17.77 by its total outstanding shares 414080000 (414.08 Million). Also see Bio-Thera Solutions Ltd (688177) cash flow conversion for how efficiently the company converts equity into cash flow.
Bio-Thera Solutions Ltd Market Cap History (2020–2026)
Bio-Thera Solutions Ltd market cap history from 2020 to 2026. Data shows change from $1.93 Billion to $1.08 Billion (-16.62% CAGR). Check today's stock price for Bio-Thera Solutions Ltd for real-time trading data and today's change.
Bio-Thera Solutions Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-Thera Solutions Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Bio-Thera Solutions Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.50x
Bio-Thera Solutions Ltd's market cap is 1.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.93 Billion | $184.99 Million | -$513.23 Million | 10.42x | N/A |
| 2021 | $1.57 Billion | $836.58 Million | $81.94 Million | 1.87x | 19.10x |
| 2022 | $1.32 Billion | $455.13 Million | -$480.40 Million | 2.90x | N/A |
| 2023 | $2.50 Billion | $704.79 Million | -$394.53 Million | 3.55x | N/A |
| 2024 | $1.17 Billion | $743.17 Million | -$510.30 Million | 1.58x | N/A |
| 2025 | $1.40 Billion | $935.22 Million | -$331.94 Million | 1.50x | N/A |
Competitor Companies of 688177 by Market Capitalization
Companies near Bio-Thera Solutions Ltd in the global market cap rankings as of November 8, 2026. Also see Bio-Thera Solutions Ltd asset portfolio for a full breakdown of the balance sheet.
Key companies related to Bio-Thera Solutions Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Bio-Thera Solutions Ltd (2020–2026)
Market capitalization of Bio-Thera Solutions Ltd from 2020 to today. Between 2020 and today, Bio-Thera Solutions Ltd's market cap moved from $1.93 Billion to $ 1.08 Billion, with a yearly change of -16.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.08 Billion | -23.21% |
| 2025 | CN¥1.40 Billion | +19.40% |
| 2024 | CN¥1.17 Billion | -53.01% |
| 2023 | CN¥2.50 Billion | +89.35% |
| 2022 | CN¥1.32 Billion | -15.68% |
| 2021 | CN¥1.57 Billion | -18.77% |
| 2020 | CN¥1.93 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Bio-Thera Solutions Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.08 Billion USD |
| MoneyControl | $1.08 Billion USD |
| MarketWatch | $1.08 Billion USD |
| marketcap.company | $1.08 Billion USD |
| Reuters | $1.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bio-Thera Solutions Ltd
Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. It offers QLETLI for the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, and uveitis; POBEVCY to treat patients with metast… Read more